Acino committed to expansion and localisation
![News Image](https://acino.swiss/wp-content/uploads/2022/05/Website-story-carousel-1.jpg)
The agreement focuses on the distribution of Allecra’s novel antibiotic drug EXBLIFEP® (cefepime/enmetazobactam) within the Republic of South Africa and...
We are proud to announce the appointment of Ingrid Eberle as Chief Compliance and Sustainability Officer, effective 1 March 2024....
For the third consecutive year, Acino South Africa has been awarded with the Top Employer certification. The Top Employer certification is one...
Antimicrobial resistance (AMR) is a global health concern that threatens the effectiveness of antibiotics and other antimicrobial medicines. It has the...
Acino, recognizes the significance of cardiovascular health and is dedicated to advancing heart care through innovative solutions and patient education....
Report reflects Acino’s commitment to Environmental, Social, and Governance sustainability including goal of reaching carbon neutrality by 2050. ZURICH, Switzerland,...
We use cookies to create statistics that help us to improve the quality of our website and your user experience. By clicking on “Accept All”, you consent to the processing of data by Acino and the transfer of data to third parties. You can also tailor your consent for specific data processing purposes. Once you have made your choice, click on “Confirm”. Find detailed information and modify your preferences at any time in our Privacy Notice.
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
We would like to set Google Analytics cookies to help us analyse the traffic on our website.